{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:27:50Z","timestamp":1793388470052,"version":"4.5.0"},"publisher-location":"Singapore","reference-count":132,"publisher":"Springer Singapore","isbn-type":[{"value":"9789813293571","type":"print"},{"value":"9789813293588","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-32-9358-8_16","type":"book-chapter","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T12:08:40Z","timestamp":1582546120000},"page":"187-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":188,"title":["Amyloid-\u03b2 and Tau at the\u00a0Crossroads of Alzheimer\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Gilbert","family":"Gallardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"issue":"9064","key":"16_CR1","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(96)10203-8","volume":"349","author":"K Maurer","year":"1997","unstructured":"Maurer K, Volk S, Gerbaldo H. Auguste D and Alzheimer\u2019s disease. Lancet. 1997;349(9064):1546\u20139.","journal-title":"Lancet"},{"issue":"3","key":"16_CR2","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/0006-291X(84)91209-9","volume":"122","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW. Alzheimer\u2019s disease and Down\u2019s syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 1984;122(3):1131\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"16_CR3","first-page":"357","volume":"2","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW, Quaranta V, Eanes ED. The amyloid deposits in Alzheimer\u2019s disease: their nature and pathogenesis. Appl Pathol. 1984;2(6):357\u201369.","journal-title":"Appl Pathol"},{"issue":"12","key":"16_CR4","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985;82(12):4245\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"16_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/archneur.1989.00520440031017","volume":"46","author":"F Lai","year":"1989","unstructured":"Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol. 1989;46(8):849\u201353.","journal-title":"Arch Neurol"},{"issue":"3","key":"16_CR6","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.410170310","volume":"17","author":"KE Wisniewski","year":"1985","unstructured":"Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer\u2019s disease in Down\u2019s syndrome. Ann Neurol. 1985;17(3):278\u201382.","journal-title":"Ann Neurol"},{"issue":"4791","key":"16_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.3810169","volume":"235","author":"D Goldgaber","year":"1987","unstructured":"Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer\u2019s disease. Science. 1987;235(4791):877\u201380.","journal-title":"Science"},{"issue":"6106","key":"16_CR8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/325733a0","volume":"325","author":"J Kang","year":"1987","unstructured":"Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al. The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987;325(6106):733\u20136.","journal-title":"Nature"},{"issue":"5054","key":"16_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"issue":"9","key":"16_CR10","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011;10(9):698\u2013712.","journal-title":"Nat Rev Drug Discov"},{"issue":"7266","key":"16_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature08538","volume":"461","author":"RJ Perrin","year":"2009","unstructured":"Perrin RJ, Fagan AM, Holtzman DM. Multimodal techniques for diagnosis and prognosis of Alzheimer\u2019s disease. Nature. 2009;461(7266):916\u201322.","journal-title":"Nature"},{"issue":"1","key":"16_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0306-4522(01)00169-5","volume":"105","author":"TC Dickson","year":"2001","unstructured":"Dickson TC, Vickers JC. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer\u2019s disease. Neuroscience. 2001;105(1):99\u2013107.","journal-title":"Neuroscience"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0072-9752(07)01222-5","volume":"89","author":"T Gomez-Isla","year":"2008","unstructured":"Gomez-Isla T, Spires T, De Calignon A, Hyman BT. Neuropathology of Alzheimer\u2019s disease. Handb Clin Neurol. 2008;89:233\u201343.","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"16_CR14","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1(1):a006189.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"16_CR15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW. Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120(3):885\u201390.","journal-title":"Biochem Biophys Res Commun"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/197192b0","volume":"197","author":"M Kidd","year":"1963","unstructured":"Kidd M. Paired helical filaments in electron microscopy of Alzheimer\u2019s disease. Nature. 1963;197:192\u20133.","journal-title":"Nature"},{"issue":"6","key":"16_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/00005072-198711000-00001","volume":"46","author":"CL Joachim","year":"1987","unstructured":"Joachim CL, Morris JH, Selkoe DJ, Kosik KS. Tau epitopes are incorporated into a range of lesions in Alzheimer\u2019s disease. J Neuropathol Exp Neurol. 1987;46(6):611\u201322.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"16_CR18","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1073\/pnas.73.11.4070","volume":"73","author":"GB Witman","year":"1976","unstructured":"Witman GB, Cleveland DW, Weingarten MD, Kirschner MW. Tubulin requires tau for growth onto microtubule initiating sites. Proc Natl Acad Sci U S A. 1976;73(11):4070\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"VM Lee","year":"2001","unstructured":"Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci. 2001;24:1121\u201359.","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"16_CR20","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/j.1460-2075.1992.tb05204.x","volume":"11","author":"J Biernat","year":"1992","unstructured":"Biernat J, Mandelkow EM, Schroter C, Lichtenberg-Kraag B, Steiner B, Berling B, et al. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 1992;11(4):1593\u20137.","journal-title":"EMBO J"},{"issue":"Pt 3","key":"16_CR21","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1042\/bj3010871","volume":"301","author":"M Goedert","year":"1994","unstructured":"Goedert M, Jakes R, Crowther RA, Cohen P, Vanmechelen E, Vandermeeren M, et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer\u2019s disease: identification of phosphorylation sites in tau protein. Biochem J. 1994;301(Pt 3):871\u20137.","journal-title":"Biochem J"},{"issue":"4","key":"16_CR22","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/0896-6273(94)90264-X","volume":"13","author":"ES Matsuo","year":"1994","unstructured":"Matsuo ES, Shin RW, Billingsley ML, Van de Voorde A, O\u2019Connor M, Trojanowski JQ, et al. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer\u2019s disease paired helical filament tau. Neuron. 1994;13(4):989\u20131002.","journal-title":"Neuron"},{"issue":"3","key":"16_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0304-3940(86)90288-0","volume":"65","author":"H Braak","year":"1986","unstructured":"Braak H, Braak E, Grundke-Iqbal I, Iqbal K. Occurrence of neuropil threads in the senile human brain and in Alzheimer\u2019s disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett. 1986;65(3):351\u20135.","journal-title":"Neurosci Lett"},{"issue":"1","key":"16_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2990.1988.tb00864.x","volume":"14","author":"H Braak","year":"1988","unstructured":"Braak H, Braak E. Neuropil threads occur in dendrites of tangle-bearing nerve cells. Neuropathol Appl Neurobiol. 1988;14(1):39\u201344.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"16_CR25","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1523\/JNEUROSCI.11-06-01748.1991","volume":"11","author":"G Perry","year":"1991","unstructured":"Perry G, Kawai M, Tabaton M, Onorato M, Mulvihill P, Richey P, et al. Neuropil threads of Alzheimer\u2019s disease show a marked alteration of the normal cytoskeleton. J Neurosci. 1991;11(6):1748\u201355.","journal-title":"J Neurosci"},{"issue":"2","key":"16_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ana.410230212","volume":"23","author":"ML Schmidt","year":"1988","unstructured":"Schmidt ML, Gur RE, Gur RC, Trojanowski JQ. Intraneuronal and extracellular neurofibrillary tangles exhibit mutually exclusive cytoskeletal antigens. Ann Neurol. 1988;23(2):184\u20139.","journal-title":"Ann Neurol"},{"issue":"4959","key":"16_CR27","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1126\/science.1971458","volume":"248","author":"C Broeckhoven Van","year":"1990","unstructured":"Van Broeckhoven C, Haan J, Bakker E, Hardy JA, Van Hul W, Wehnert A, et al. Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science. 1990;248(4959):1120\u20132.","journal-title":"Science"},{"issue":"4959","key":"16_CR28","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1126\/science.2111584","volume":"248","author":"E Levy","year":"1990","unstructured":"Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, et al. Mutation of the Alzheimer\u2019s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 1990;248(4959):1124\u20136.","journal-title":"Science"},{"issue":"6311","key":"16_CR29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature. 1991;349(6311):704\u20136.","journal-title":"Nature"},{"issue":"6347","key":"16_CR30","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/353844a0","volume":"353","author":"MC Chartier-Harlin","year":"1991","unstructured":"Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, et al. Early-onset Alzheimer\u2019s disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature. 1991;353(6347):844\u20136.","journal-title":"Nature"},{"issue":"5028","key":"16_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.1925564","volume":"254","author":"J Murrell","year":"1991","unstructured":"Murrell J, Farlow M, Ghetti B, Benson MD. A mutation in the amyloid precursor protein associated with hereditary Alzheimer\u2019s disease. Science. 1991;254(5028):97\u20139.","journal-title":"Science"},{"issue":"26","key":"16_CR32","doi-asserted-by":"crossref","first-page":"17741","DOI":"10.1016\/S0021-9258(17)32503-6","volume":"269","author":"C Haass","year":"1994","unstructured":"Haass C, Hung AY, Selkoe DJ, Teplow DB. Mutations associated with a locus for familial Alzheimer\u2019s disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem. 1994;269(26):17741\u20138.","journal-title":"J Biol Chem"},{"issue":"5163","key":"16_CR33","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.8191290","volume":"264","author":"N Suzuki","year":"1994","unstructured":"Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr, Eckman C, et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 1994;264(5163):1336\u201340.","journal-title":"Science"},{"issue":"5","key":"16_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng0892-345","volume":"1","author":"M Mullan","year":"1992","unstructured":"Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, et al. A pathogenic mutation for probable Alzheimer\u2019s disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet. 1992;1(5):345\u20137.","journal-title":"Nat Genet"},{"issue":"5094","key":"16_CR35","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1126\/science.8424174","volume":"259","author":"XD Cai","year":"1993","unstructured":"Cai XD, Golde TE, Younkin SG. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science. 1993;259(5094):514\u20136.","journal-title":"Science"},{"issue":"6405","key":"16_CR36","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/360672a0","volume":"360","author":"M Citron","year":"1992","unstructured":"Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer\u2019s disease increases beta-protein production. Nature. 1992;360(6405):672\u20134.","journal-title":"Nature"},{"issue":"1","key":"16_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet. 2006;38(1):24\u20136.","journal-title":"Nat Genet"},{"issue":"7409","key":"16_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, et al. A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature. 2012;488(7409):96\u20139.","journal-title":"Nature"},{"issue":"9","key":"16_CR39","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nn0901-887","volume":"4","author":"C Nilsberth","year":"2001","unstructured":"Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, et al. The \u2018Arctic\u2019 APP mutation (E693G) causes Alzheimer\u2019s disease by enhanced Abeta protofibril formation. Nat Neurosci. 2001;4(9):887\u201393.","journal-title":"Nat Neurosci"},{"issue":"6880","key":"16_CR40","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416(6880):535\u20139.","journal-title":"Nature"},{"issue":"5","key":"16_CR41","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nn842","volume":"5","author":"JC Dodart","year":"2002","unstructured":"Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, et al. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer\u2019s disease model. Nat Neurosci. 2002;5(5):452\u20137.","journal-title":"Nat Neurosci"},{"issue":"7082","key":"16_CR42","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesne","year":"2006","unstructured":"Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 2006;440(7082):352\u20137.","journal-title":"Nature"},{"issue":"8","key":"16_CR43","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat Med. 1996;2(8):864\u201370.","journal-title":"Nat Med"},{"issue":"6534","key":"16_CR44","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature. 1995;375(6534):754\u201360.","journal-title":"Nature"},{"issue":"6543","key":"16_CR45","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature. 1995;376(6543):775\u20138.","journal-title":"Nature"},{"issue":"1","key":"16_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nm0197-67","volume":"3","author":"M Citron","year":"1997","unstructured":"Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, et al. Mutant presenilins of Alzheimer\u2019s disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med. 1997;3(1):67\u201372.","journal-title":"Nat Med"},{"issue":"6727","key":"16_CR47","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"MS Wolfe","year":"1999","unstructured":"Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 1999;398(6727):513\u20137.","journal-title":"Nature"},{"issue":"6800","key":"16_CR48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/35024009","volume":"407","author":"G Yu","year":"2000","unstructured":"Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, et al. Nicastrin modulates presenilin-mediated notch\/glp-1 signal transduction and betaAPP processing. Nature. 2000;407(6800):48\u201354.","journal-title":"Nature"},{"issue":"1","key":"16_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1534-5807(02)00189-2","volume":"3","author":"R Francis","year":"2002","unstructured":"Francis R, McGrath G, Zhang J, Ruddy DA, Sym M, Apfeld J, et al. aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev Cell. 2002;3(1):85\u201397.","journal-title":"Dev Cell"},{"issue":"5","key":"16_CR50","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(5):1977\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"16_CR51","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(20):9649\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5123","key":"16_CR52","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261(5123):921\u20133.","journal-title":"Science"},{"issue":"9","key":"16_CR53","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/mp.2011.52","volume":"16","author":"E Genin","year":"2011","unstructured":"Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry. 2011;16(9):903\u20137.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"16_CR54","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","volume":"47","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, et al. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer\u2019s disease model. Ann Neurol. 2000;47(6):739\u201347.","journal-title":"Ann Neurol"},{"issue":"3","key":"16_CR55","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","volume":"9","author":"AM Fagan","year":"2002","unstructured":"Fagan AM, Watson M, Parsadanian M, Bales KR, Paul SM, Holtzman DM. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2002;9(3):305\u201318.","journal-title":"Neurobiol Dis"},{"issue":"7673","key":"16_CR56","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549(7673):523\u20137.","journal-title":"Nature"},{"issue":"9","key":"16_CR57","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012;367(9):795\u2013804.","journal-title":"N Engl J Med"},{"issue":"3","key":"16_CR58","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"AM Fagan","year":"2006","unstructured":"Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol. 2006;59(3):512\u20139.","journal-title":"Ann Neurol"},{"issue":"12","key":"16_CR59","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1001\/archneurol.2011.183","volume":"68","author":"CR Jack Jr","year":"2011","unstructured":"Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Aisen PS, Trojanowski JQ, et al. Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol. 2011;68(12):1526\u201335.","journal-title":"Arch Neurol"},{"issue":"3","key":"16_CR60","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","volume":"64","author":"AM Fagan","year":"2007","unstructured":"Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol. 2007;64(3):343\u20139.","journal-title":"Arch Neurol"},{"issue":"1","key":"16_CR61","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol. 2010;9(1):119\u201328.","journal-title":"Lancet Neurol"},{"issue":"15","key":"16_CR62","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","volume":"73","author":"WJ Jagust","year":"2009","unstructured":"Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, et al. Relationships between biomarkers in aging and dementia. Neurology. 2009;73(15):1193\u20139.","journal-title":"Neurology"},{"issue":"16","key":"16_CR63","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1212\/WNL.0b013e3182661f74","volume":"79","author":"PM Doraiswamy","year":"2012","unstructured":"Doraiswamy PM, Sperling RA, Coleman RE, Johnson KA, Reiman EM, Davis MD, et al. Amyloid-beta assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology. 2012;79(16):1636\u201344.","journal-title":"Neurology"},{"issue":"9","key":"16_CR64","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/mp.2014.9","volume":"19","author":"PM Doraiswamy","year":"2014","unstructured":"Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, et al. Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. Mol Psychiatry. 2014;19(9):1044\u201351.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"16_CR65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/alzrt158","volume":"5","author":"K Ong","year":"2013","unstructured":"Ong K, Villemagne VL, Bahar-Fuchs A, Lamb F, Chetelat G, Raniga P, et al. (18)F-florbetaben Abeta imaging in mild cognitive impairment. Alzheimers Res Ther. 2013;5(1):4.","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"16_CR66","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/archneurol.2011.167","volume":"68","author":"MR Sabuncu","year":"2011","unstructured":"Sabuncu MR, Desikan RS, Sepulcre J, Yeo BT, Liu H, Schmansky NJ, et al. The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol. 2011;68(8):1040\u20138.","journal-title":"Arch Neurol"},{"issue":"7","key":"16_CR67","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1212\/WNL.0b013e318246d67a","volume":"78","author":"G Chetelat","year":"2012","unstructured":"Chetelat G, Villemagne VL, Villain N, Jones G, Ellis KA, Ames D, et al. Accelerated cortical atrophy in cognitively normal elderly with high beta-amyloid deposition. Neurology. 2012;78(7):477\u201384.","journal-title":"Neurology"},{"issue":"3","key":"16_CR68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.21955","volume":"67","author":"G Chetelat","year":"2010","unstructured":"Chetelat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, et al. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol. 2010;67(3):317\u201324.","journal-title":"Ann Neurol"},{"issue":"1","key":"16_CR69","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/ana.20889","volume":"60","author":"HA Archer","year":"2006","unstructured":"Archer HA, Edison P, Brooks DJ, Barnes J, Frost C, Yeatman T, et al. Amyloid load and cerebral atrophy in Alzheimer\u2019s disease: an 11C-PIB positron emission tomography study. Ann Neurol. 2006;60(1):145\u20137.","journal-title":"Ann Neurol"},{"key":"16_CR70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2015.10.013","volume":"39","author":"KA Andrews","year":"2016","unstructured":"Andrews KA, Frost C, Modat M, Cardoso MJ, Rowe CC, Villemagne V, et al. Acceleration of hippocampal atrophy rates in asymptomatic amyloidosis. Neurobiol Aging. 2016;39:99\u2013107.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"16_CR71","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/jamaneurol.2013.1062","volume":"70","author":"V Dore","year":"2013","unstructured":"Dore V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetelat G, et al. Cross-sectional and longitudinal analysis of the relationship between Abeta deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. JAMA Neurol. 2013;70(7):903\u201311.","journal-title":"JAMA Neurol"},{"issue":"3","key":"16_CR72","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neurobiolaging.2012.06.014","volume":"34","author":"RA Sperling","year":"2013","unstructured":"Sperling RA, Johnson KA, Doraiswamy PM, Reiman EM, Fleisher AS, Sabbagh MN, et al. Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging. 2013;34(3):822\u201331.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"16_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058816","volume":"8","author":"KA Andrews","year":"2013","unstructured":"Andrews KA, Modat M, Macdonald KE, Yeatman T, Cardoso MJ, Leung KK, et al. Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials. PLoS One. 2013;8(3):e58816.","journal-title":"PLoS One"},{"issue":"4","key":"16_CR74","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239\u201359.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"16_CR75","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ana.410410106","volume":"41","author":"T Gomez-Isla","year":"1997","unstructured":"Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease. Ann Neurol. 1997;41(1):17\u201324.","journal-title":"Ann Neurol"},{"issue":"9","key":"16_CR76","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1212\/WNL.42.9.1681","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer\u2019s disease. Neurology. 1992;42(9):1681\u20138.","journal-title":"Neurology"},{"issue":"4","key":"16_CR77","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0197-4580(91)90006-6","volume":"12","author":"JL Price","year":"1991","unstructured":"Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer\u2019s disease. Neurobiol Aging. 1991;12(4):295\u2013312.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"16_CR78","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","volume":"45","author":"JL Price","year":"1999","unstructured":"Price JL, Morris JC. Tangles and plaques in nondemented aging and \"preclinical\" Alzheimer\u2019s disease. Ann Neurol. 1999;45(3):358\u201368.","journal-title":"Ann Neurol"},{"issue":"1","key":"16_CR79","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016;79(1):110\u20139.","journal-title":"Ann Neurol"},{"issue":"338","key":"16_CR80","doi-asserted-by":"publisher","first-page":"338ra66","DOI":"10.1126\/scitranslmed.aaf2362","volume":"8","author":"MR Brier","year":"2016","unstructured":"Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, et al. Tau and Abeta imaging, CSF measures, and cognition in Alzheimer\u2019s disease. Sci Transl Med. 2016;8(338):338ra66.","journal-title":"Sci Transl Med"},{"issue":"12","key":"16_CR81","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain. 2017;140(12):3286\u2013300.","journal-title":"Brain"},{"issue":"2","key":"16_CR82","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-010-0789-4","volume":"121","author":"H Braak","year":"2011","unstructured":"Braak H, Del Tredici K. The pathological process underlying Alzheimer\u2019s disease in individuals under thirty. Acta Neuropathol. 2011;121(2):171\u201381.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"16_CR83","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","volume":"30","author":"JL Price","year":"2009","unstructured":"Price JL, McKeel DW Jr, Buckles VD, Roe CM, Xiong C, Grundman M, et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging. 2009;30(7):1026\u201336.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"16_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","volume":"68","author":"PT Nelson","year":"2009","unstructured":"Nelson PT, Braak H, Markesbery WR. Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol. 2009;68(1):1\u201314.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"16_CR85","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1474-4422(13)70194-7","volume":"12","author":"SJ Vos","year":"2013","unstructured":"Vos SJ, Xiong C, Visser PJ, Jasielec MS, Hassenstab J, Grant EA, et al. Preclinical Alzheimer\u2019s disease and its outcome: a longitudinal cohort study. Lancet Neurol. 2013;12(10):957\u201365.","journal-title":"Lancet Neurol"},{"issue":"19","key":"16_CR86","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1212\/WNL.0b013e3182918ca6","volume":"80","author":"CM Roe","year":"2013","unstructured":"Roe CM, Fagan AM, Grant EA, Hassenstab J, Moulder KL, Maue Dreyfus D, et al. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology. 2013;80(19):1784\u201391.","journal-title":"Neurology"},{"issue":"4","key":"16_CR87","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12(4):357\u201367.","journal-title":"Lancet Neurol"},{"issue":"8","key":"16_CR88","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/ene.12398","volume":"21","author":"X Chen","year":"2014","unstructured":"Chen X, Li M, Wang S, Zhu H, Xiong Y, Liu X. Pittsburgh compound B retention and progression of cognitive status--a meta-analysis. Eur J Neurol. 2014;21(8):1060\u20137.","journal-title":"Eur J Neurol"},{"issue":"22","key":"16_CR89","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1001\/jama.2017.6669","volume":"317","author":"MC Donohue","year":"2017","unstructured":"Donohue MC, Sperling RA, Petersen R, Sun CK, Weiner MW, Aisen PS. Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons. JAMA. 2017;317(22):2305\u201316.","journal-title":"JAMA"},{"key":"16_CR90","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.nbd.2016.05.016","volume":"94","author":"B Combs","year":"2016","unstructured":"Combs B, Hamel C, Kanaan NM. Pathological conformations involving the amino terminus of tau occur early in Alzheimer\u2019s disease and are differentially detected by monoclonal antibodies. Neurobiol Dis. 2016;94:18\u201331.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"16_CR91","doi-asserted-by":"publisher","first-page":"826.e15","DOI":"10.1016\/j.neurobiolaging.2011.06.006","volume":"33","author":"NM Kanaan","year":"2012","unstructured":"Kanaan NM, Morfini G, Pigino G, LaPointe NE, Andreadis A, Song Y, et al. Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport. Neurobiol Aging. 2012;33(4):826.e15\u201330.","journal-title":"Neurobiol Aging"},{"issue":"Pt 21","key":"16_CR92","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1242\/jcs.113.21.3737","volume":"113","author":"A Abraha","year":"2000","unstructured":"Abraha A, Ghoshal N, Gamblin TC, Cryns V, Berry RW, Kuret J, et al. C-terminal inhibition of tau assembly in vitro and in Alzheimer\u2019s disease. J Cell Sci. 2000;113(Pt 21):3737\u201345.","journal-title":"J Cell Sci"},{"issue":"7","key":"16_CR93","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol. 2009;11(7):909\u201313.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"16_CR94","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","volume":"33","author":"M Iba","year":"2013","unstructured":"Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer\u2019s-like tauopathy. J Neurosci. 2013;33(3):1024\u201337.","journal-title":"J Neurosci"},{"issue":"14","key":"16_CR95","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","volume":"16","author":"T Gomez-Isla","year":"1996","unstructured":"Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease. J Neurosci. 1996;16(14):4491\u2013500.","journal-title":"J Neurosci"},{"issue":"8925","key":"16_CR96","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(94)92338-8","volume":"344","author":"MJ West","year":"1994","unstructured":"West MJ, Coleman PD, Flood DG, Troncoso JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer\u2019s disease. Lancet. 1994;344(8925):769\u201372.","journal-title":"Lancet"},{"issue":"6","key":"16_CR97","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1001\/jamaneurol.2014.446","volume":"71","author":"N Mattsson","year":"2014","unstructured":"Mattsson N, Insel PS, Nosheny R, Tosun D, Trojanowski JQ, Shaw LM, et al. Emerging beta-amyloid pathology and accelerated cortical atrophy. JAMA Neurol. 2014;71(6):725\u201334.","journal-title":"JAMA Neurol"},{"issue":"5534","key":"16_CR98","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J Gotz","year":"2001","unstructured":"Gotz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 2001;293(5534):1491\u20135.","journal-title":"Science"},{"issue":"6","key":"16_CR99","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.2353\/ajpath.2007.070403","volume":"171","author":"T Bolmont","year":"2007","unstructured":"Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M, et al. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. Am J Pathol. 2007;171(6):2012\u201320.","journal-title":"Am J Pathol"},{"issue":"5534","key":"16_CR100","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001;293(5534):1487\u201391.","journal-title":"Science"},{"issue":"4","key":"16_CR101","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.2353\/ajpath.2010.100346","volume":"177","author":"DE Hurtado","year":"2010","unstructured":"Hurtado DE, Molina-Porcel L, Iba M, Aboagye AK, Paul SM, Trojanowski JQ, et al. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. Am J Pathol. 2010;177(4):1977\u201388.","journal-title":"Am J Pathol"},{"issue":"7","key":"16_CR102","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.ajpath.2017.03.011","volume":"187","author":"RE Bennett","year":"2017","unstructured":"Bennett RE, DeVos SL, Dujardin S, Corjuc B, Gor R, Gonzalez J, et al. Enhanced Tau Aggregation in the Presence of Amyloid beta. Am J Pathol. 2017;187(7):1601\u201312.","journal-title":"Am J Pathol"},{"issue":"12","key":"16_CR103","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1084\/jem.20160833","volume":"213","author":"JL Guo","year":"2016","unstructured":"Guo JL, Narasimhan S, Changolkar L, He Z, Stieber A, Zhang B, et al. Unique pathological tau conformers from Alzheimer\u2019s brains transmit tau pathology in nontransgenic mice. J Exp Med. 2016;213(12):2635\u201354.","journal-title":"J Exp Med"},{"issue":"1","key":"16_CR104","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, et al. Amyloid-beta plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018;24(1):29\u201338.","journal-title":"Nat Med"},{"issue":"4","key":"16_CR105","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0896-6273(95)90232-5","volume":"14","author":"J Busciglio","year":"1995","unstructured":"Busciglio J, Lorenzo A, Yeh J, Yankner BA. beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 1995;14(4):879\u201388.","journal-title":"Neuron"},{"issue":"2","key":"16_CR106","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1471-4159.1993.tb03173.x","volume":"60","author":"M Arioka","year":"1993","unstructured":"Arioka M, Tsukamoto M, Ishiguro K, Kato R, Sato K, Imahori K, et al. Tau protein kinase II is involved in the regulation of the normal phosphorylation state of tau protein. J Neurochem. 1993;60(2):461\u20138.","journal-title":"J Neurochem"},{"issue":"9","key":"16_CR107","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1073\/pnas.092136199","volume":"99","author":"M Rapoport","year":"2002","unstructured":"Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A. Tau is essential to beta -amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A. 2002;99(9):6364\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"16_CR108","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1038\/emboj.2013.207","volume":"32","author":"H Zempel","year":"2013","unstructured":"Zempel H, Luedtke J, Kumar Y, Biernat J, Dawson H, Mandelkow E, et al. Amyloid-beta oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin. EMBO J. 2013;32(22):2920\u201337.","journal-title":"EMBO J"},{"issue":"4","key":"16_CR109","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1083\/jcb.200605187","volume":"175","author":"ME King","year":"2006","unstructured":"King ME, Kan HM, Baas PW, Erisir A, Glabe CG, Bloom GS. Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid. J Cell Biol. 2006;175(4):541\u20136.","journal-title":"J Cell Biol"},{"issue":"5","key":"16_CR110","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1523\/JNEUROSCI.2610-10.2011","volume":"31","author":"OA Shipton","year":"2011","unstructured":"Shipton OA, Leitz JR, Dworzak J, Acton CE, Tunbridge EM, Denk F, et al. Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. J Neurosci. 2011;31(5):1688\u201392.","journal-title":"J Neurosci"},{"issue":"3","key":"16_CR111","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models. Cell. 2010;142(3):387\u201397.","journal-title":"Cell"},{"issue":"5825","key":"16_CR112","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer\u2019s disease mouse model. Science. 2007;316(5825):750\u20134.","journal-title":"Science"},{"issue":"6","key":"16_CR113","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.ajpath.2012.08.012","volume":"181","author":"K Leroy","year":"2012","unstructured":"Leroy K, Ando K, Laporte V, Dedecker R, Suain V, Authelet M, et al. Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP\/PS1 mice. Am J Pathol. 2012;181(6):1928\u201340.","journal-title":"Am J Pathol"},{"issue":"2","key":"16_CR114","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"2","key":"16_CR115","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):107\u201316.","journal-title":"N Engl J Med"},{"issue":"4","key":"16_CR116","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.20041611","volume":"201","author":"K Takahashi","year":"2005","unstructured":"Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med. 2005;201(4):647\u201357.","journal-title":"J Exp Med"},{"issue":"5","key":"16_CR117","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/eji.200636837","volume":"37","author":"L Piccio","year":"2007","unstructured":"Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, Cross AH, et al. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol. 2007;37(5):1290\u2013301.","journal-title":"Eur J Immunol"},{"key":"16_CR118","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-9-20","volume":"9","author":"JD Ulrich","year":"2014","unstructured":"Ulrich JD, Finn MB, Wang Y, Shen A, Mahan TE, Jiang H, et al. Altered microglial response to Abeta plaques in APPPS1-21 mice heterozygous for TREM2. Mol Neurodegener. 2014;9:20.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"16_CR119","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell. 2015;160(6):1061\u201371.","journal-title":"Cell"},{"issue":"5","key":"16_CR120","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med. 2016;213(5):667\u201375.","journal-title":"J Exp Med"},{"issue":"1","key":"16_CR121","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuron.2016.09.016","volume":"92","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;92(1):252\u201364.","journal-title":"Neuron"},{"issue":"11","key":"16_CR122","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015;18(11):1584\u201393.","journal-title":"Nat Neurosci"},{"issue":"1","key":"16_CR123","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","volume":"68","author":"K Bhaskar","year":"2010","unstructured":"Bhaskar K, Konerth M, Kokiko-Cochran ON, Cardona A, Ransohoff RM, Lamb BT. Regulation of tau pathology by the microglial fractalkine receptor. Neuron. 2010;68(1):19\u201331.","journal-title":"Neuron"},{"issue":"Pt 6","key":"16_CR124","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/brain\/awv081","volume":"138","author":"N Maphis","year":"2015","unstructured":"Maphis N, Xu G, Kokiko-Cochran ON, Jiang S, Cardona A, Ransohoff RM, et al. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain. 2015;138(Pt 6):1738\u201355.","journal-title":"Brain"},{"issue":"5","key":"16_CR125","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.neurobiolaging.2004.01.007","volume":"25","author":"RG Nagele","year":"2004","unstructured":"Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC. Contribution of glial cells to the development of amyloid plaques in Alzheimer\u2019s disease. Neurobiol Aging. 2004;25(5):663\u201374.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"16_CR126","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol. 2016;131(1):87\u2013102.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"16_CR127","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/jnen\/nlx007","volume":"76","author":"GG Kovacs","year":"2017","unstructured":"Kovacs GG, Robinson JL, Xie SX, Lee EB, Grossman M, Wolk DA, et al. Evaluating the patterns of aging-related tau astrogliopathy unravels novel insights into brain aging and neurodegenerative diseases. J Neuropathol Exp Neurol. 2017;76(4):270\u201388.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"16_CR128","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","volume":"85","author":"H Lian","year":"2015","unstructured":"Lian H, Yang L, Cole A, Sun L, Chiang AC, Fowler SW, et al. NFkappaB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer\u2019s disease. Neuron. 2015;85(1):101\u201315.","journal-title":"Neuron"},{"issue":"6","key":"16_CR129","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1073\/pnas.94.6.2642","volume":"94","author":"B Kaltschmidt","year":"1997","unstructured":"Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A. 1997;94(6):2642\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6286","key":"16_CR130","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712\u20136.","journal-title":"Science"},{"issue":"18","key":"16_CR131","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, et al. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32(18):6391\u2013410.","journal-title":"J Neurosci"},{"issue":"7638","key":"16_CR132","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"}],"container-title":["Advances in Experimental Medicine and Biology","Tau Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-32-9358-8_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T21:11:43Z","timestamp":1722460303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-32-9358-8_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789813293571","9789813293588"],"references-count":132,"URL":"https:\/\/doi.org\/10.1007\/978-981-32-9358-8_16","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"25 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}